Improvements in transcatheter aortic valve implantation outcomes in lower surgical risk patients: A glimpse into the future

Journal of the American College of Cardiology

Volumn 59, Issue 3, 2012, Pages 280-287

  Lange, Ruediger ^a   Bleiziffer, Sabine ^a   Mazzitelli, Domenico ^a   Elhmidi, Yacine ^a   Opitz, Anke ^a   Krane, Marcus ^a   Deutsch, Marcus Andre ^a   Ruge, Hendrik ^a   Brockmann, Gernot ^a   Voss, Bernhard ^a   Schreiber, Christian ^a   Tassani, Peter ^a   Piazza, Nicolo ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

aortic stenosis; transcatheter aortic; valve implantation

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

AGED; ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; FEMALE; HUMAN; LOWER SURGICAL RISK PATIENT; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PATIENT; PATIENT SELECTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SCORING SYSTEM; SURGICAL RISK; SURVIVAL TIME; TRANSCATHETER AORTIC VALVE IMPLANTATION; TREATMENT INDICATION; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; AORTIC VALVE STENOSIS; FEMALE; FORECASTING; HEART CATHETERIZATION; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MALE; RISK FACTORS; TREATMENT OUTCOME;

EID: 84855704273     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2011.10.868     Document Type: Article

References (21)

1. P.A. Lemos, C.H. Lee, M. Degertekin Early outcome after sirolimus-eluting stent implantation in patients with acute coronary syndromes: insights from the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry J Am Coll Cardiol 41 2003 2093 2099 (Pubitemid 36677137)
2. A.T. Ong, P.W. Serruys, J. Aoki The unrestricted use of paclitaxel- versus sirolimus-eluting stents for coronary artery disease in an unselected population: one-year results of the Taxus-Stent Evaluated at Rotterdam Cardiology Hospital (T-SEARCH) registry J Am Coll Cardiol 45 2005 1135 1141 (Pubitemid 40432449)
3. A. Hoye, K. Tanabe, P.A. Lemos Significant reduction in restenosis after the use of sirolimus-eluting stents in the treatment of chronic total occlusions J Am Coll Cardiol 43 2004 1954 1958 (Pubitemid 38686787)
4. S.V. Rao, R.E. Shaw, R.G. Brindis, L.W. Klein, W.S. Weintraub, E.D. Peterson On- versus off-label use of drug-eluting coronary stents in clinical practice (report from the American College of Cardiology National Cardiovascular Data Registry [NCDR]) Am J Cardiol 97 2006 1478 1481
5. N. Beohar, C.J. Davidson, K.E. Kip Outcomes and complications associated with off-label and untested use of drug-eluting stents JAMA 297 2007 1992 2000 (Pubitemid 46740351)
6. C.L. Grines Off-label use of drug-eluting stents putting it in perspective J Am Coll Cardiol 51 2008 615 617
7. N. Piazza, A. Otten, C. Schultz Adherence to patient selection criteria in patients undergoing transcatheter aortic valve implantation with the 18F CoreValve ReValvingTM System: results from a single-center study Heart 96 2010 19 26
8. S. Bleiziffer, H. Ruge, D. Mazzitelli Results of percutaneous and transapical transcatheter aortic valve implantation performed by a surgical team Eur J Cardiothorac Surg 35 2009 615 620
9. J.G. Webb, L. Altwegg, R.H. Boone Transcatheter aortic valve implantation: impact on clinical and valve-related outcomes Circulation 119 2009 3009 3016
10. D. Himbert, F. Descoutures, N. Al-Attar Results of transfemoral or transapical aortic valve implantation following a uniform assessment in high-risk patients with aortic stenosis J Am Coll Cardiol 54 2009 303 311
11. E. Grube, L. Buellesfeld, R. Mueller Progress and current status of percutaneous aortic valve replacement: results of three device generations of the CoreValve Revalving system Circ Cardiovasc Interv 1 2008 167 175
12. N. Piazza, E. Grube, U. Gerckens Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18F) CoreValve ReValving System: results from the multicenter, expanded evaluation registry 1-year following CE mark approval Eurointervention 4 2008 242 249
13. A.M. Moynagh, D.J. Scott, A. Baumbach CoreValve transcatheter aortic valve implantation via the subclavian artery comparison with the transfemoral approach J Am Coll Cardiol 57 2011 634 635
14. C. Tamburino, D. Capodanno, A. Ramondo Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis Circulation 123 2011 299 308
15. T. Lefevre, A.P. Kappetein, E. Wolner One year follow-up of the multi-centre European PARTNER transcatheter heart valve study Eur Heart J 32 2011 148 157
16. M.B. Leon, C.R. Smith, M. Mack Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery N Engl J Med 363 2010 1597 1607
17. H. Eltchaninoff, A. Prat, M. Gilard FRANCE Registry Investigators Transcatheter aortic valve implantation: early results of the FRANCE (FRench Aortic National CoreValve and Edwards) registry Eur Heart J 32 2011 191 197
18. S. Bleiziffer, H. Ruge, D. Mazzitelli Results of percutaneous and transapical transcatheter aortic valve implantation performed by a surgical team Eur J Cardiothorac Surg 35 2009 615 620 discussion 6201
19. E.A. Grossi, C.F. Schwartz, P.J. Yu High-risk aortic valve replacement: are the outcomes as bad as predicted Ann Thorac Surg 85 2008 102 106
20. N. Piazza, M. van Gameren, P. Jni A Comparison of patient characteristics and 30-day mortality outcomes after transcatheter aortic valve implantation and surgical aortic valve replacement for the treatment of aortic stenosis: a two-center study EuroIntervention 5 2009 580 588
21. P. Kahlert, H. Eggebrecht, R. Erbel, S. Sack A modified "preclosure" technique after percutaneous aortic valve replacement Catheter Cardiovasc Interv 72 2008 877 884